Test Directory

Test Code
2026
Test Name
Chondrodysplasia Punctata And Related Disorders NGS Panel
CPT Codes
81479
Expected Turnaround Time
Typically 2 to 4 weeks from receipt of a sample in the laboratory. All cases involving ongoing pregnancies will be expedited.
Clinical Utility
Genetic analysis to provide a molecular diagnosis of this disorder. Recommended for individuals with a personal and/or family history of this disorder to ensure appropriate treatment and establish recurrence risk for family members.
Specimen and Container Info

Non-Prenatal Specimens

Preferred/Alternate

Specimen Type

Containers

Volume

Preferred Specimen Type

Whole Blood

Lavender Top (EDTA)

3 mL

Alternate Specimen Type

Genomic DNA

1.5 mL Tube

3 µg (at a concentration of at least 30 ng/µl), preferably in TE solution.

Alternate Specimen Type

Fibroblasts

T-25 Flasks

2 confluent T-25 flasks, filled to capacity

Alternate Specimen Type

Saliva (Whole blood is recommended for CNV)

DNA Self-Collection Kit or Oragene Saliva Collection Kit for Young Children

Follow kit instructions (www.dnagenotek.com)

Prenatal Specimens

Either specimen type below is acceptable.

Specimen Type

Containers

Volume

Cultured cells

T-25 Flasks

2 confluent T-25 flasks derived from amnio or CVS samples.

Genomic DNA

1.5 mL Tube

3 µg (at a concentration of at least 30 ng/µl), preferably in TE solution.

NOTE: For specimens from outside of North America, the preferred specimen type is Genomic DNA. HNL Genomics does not recommend shipping whole blood or cultured cells from any location other than the United States, Canada, or Mexico.

Transport Instructions
  • Transport at room temperature within 24 hours.
  • If the specimen cannot be transported to the lab within 24 hours, refrigerate for up to 72 hours.
  • Do not freeze or expose to extreme temperatures, refrigerate for up to 72 hours if cannot be transported to lab within 24 hours. 
Stability Requirements

Room Temperature

24 hours

Refrigerated

72 hours

Causes for Rejection
  • Improperly labeled specimen (minimum of two patient identifiers)
  • Inappropriate specimen type
  • Incomplete or incorrect test request form
  • Insufficient volume
  • Specimen has leaked in transit
  • Specimen without a test order
Methodology
Next Generation Sequencing and Copy Number Variation Analysis
Performing Location
Genomics - Snowdrift
Alternate Names
  • CDPX
  • RCDP
  • PFCRD
  • GRBGD
  • KTLS
  • CDPX2
Description

The Chondrodysplasia punctata and related disorders NGS panel consists of ten genes for X-linked chondrodysplasia punctata (CDPX), rhizomelic chondrodysplasia punctata (RCDP), peroxisomal fatty acyl-CoA reductase 1 disorder (PFCRD), Greenberg skeletal dysplasia (GRBGD), CHILD syndrome and Keutel syndrome (KTLS). Common features in CDPX include punctiform calcification of bones and stippled epiphyses. CDPX2, also known as Conradi-Hunermann-Happle syndrome, is characterized by asymmetric shortening of the limbs, flat face, saddle nose, cataracts, ichthyosis, coarse hair, and alopecia. CDPX2 is associated with striking clinical intra- and inter-familial variability, from mild to lethal. CDPX1 is characterized by short distal phalanges, moderate growth disturbance, symmetric involvement of limbs, nasal hypoplasia and dysmorphic faces. Ichthyosis and developmental delay have been reported in contiguous gene syndrome patients. RCDP is characterized by disproportionate short stature with rhizomelic limb shortening, congenital cataracts, distinct facial features, severe intellectual disability, and seizures. Radiographs of infants with RCDP show punctate calcifications in the epiphyseal cartilage and coronal clefts of the vertebral bodies. The punctate calcifications generally resolve by one year of age leaving abnormal epiphyses and flared, irregular metaphyses. Most individuals with classic RCDP do not survive the first decade of life. PFCRD shares some features of RCDP, but this disorder is mainly characterized by growth retardation, microcephaly, severely delayed psychomotor development and seizures. The main findings in GRBGD include severe shortening of all long bones with a moth-eaten radiographic appearance, platyspondyly, disorganization of chondroosseous calcification, ectopic ossification centers, and hydrops fetalis. CHILD syndrome clinically overlaps with CDPX2. Its clinical findings consist of congenital hemidysplasia with ichthyosiform erythrodema and limb defects. KTLS is characterized by multiple peripheral pulmonary stenoses, brachytelephalangy, inner ear deafness, and abnormal cartilage ossification or calcification.

The Chondrodysplasia punctata and related disorders NGS panel consists of ten genes: AGPS, ARSL, EBP, FAR1, GNPAT, LBR, MGP, NSDHL, PEX5 and PEX7.

 

Gene

Disorder

MIM

Inheritance

AGPS

Rhizomelic chondrodysplasia punctata, type 3 (RCDP3)

600121

AR

ARSL

Chondrodysplasia punctata, X-linked recessive (CDPX1)

302950

XLR

EBP

Chondrodysplasia punctata, X-linked dominant (CDPX2)

302960

XLD

FAR1

Peroxisomal fatty acyl-CoA reductase 1 disorder (PFCRD)

616154

AR

GNPAT

Rhizomelic chondrodysplasia punctata, type 2 (RCDP2)

222765

AR

LBR

Greenberg skeletal dysplasia (GRBGD)

600024

AR

MGP

Keutel syndrome (KTLS)

245150

AR

NSDHL

CHILD syndrome

308050

XLD

PEX5

Rhizomelic chondrodysplasia punctata, type 5 (RCDP5)

616716

AR

PEX7

Rhizomelic chondrodysplasia punctata, type 1 (RCDP1)

215100

AR

Testing Schedule
Monday-Friday
Genes
AGPS, ARSL, EBP, FAR1, GNPAT, LBR, MGP, NSDHL, PEX5, PEX7
MIM
215100, 222765, 245150, 302950, 302960, 308050, 600024, 600121
Disease Group
Dysmorphology, Metabolic and Endocrine, Neuromuscular, Skeletal Disorders